-
Added complexity to genotype–phenotype relationships in primary ciliary dyskinesia: TAS2R38 as a gene modifier Thorax (IF 9.0) Pub Date : 2024-12-01 Katherine Alexandra Despotes, Stephanie D Davis
Primary ciliary dyskinesia (PCD), an inherited motile ciliopathy, is characterised by recurrent upper and lower respiratory tract infections, organ laterality defects, subfertility and neonatal respiratory distress due to impaired ciliary function.1 Over 50 PCD disease-causing genes have been identified that impact the structure and function of the cilia (figure 1, originally in Despotes et al 1).
-
Collagen neoepitopes in sarcoidosis: what do they tell us? Thorax (IF 9.0) Pub Date : 2024-12-01 Daniel A Culver, Pauline Teresa Lukey
Fibrosis is scarring due to the replacement of tissue architecture by extracellular matrix (ECM), which consists largely of collagen. Scarring progressively destroys organ structure and thereby impairs function. Accumulation of collagen is thought to be due to an increase in production, a reduction in degradation of collagen or a combination of both.1 If so, we might expect the ratio of production
-
Imaging in early tuberculosis Thorax (IF 9.0) Pub Date : 2024-12-01 Robert Wilkinson
Tuberculosis (TB) is a pressing global human health problem that resulted in over 10 million cases and 1.3 million deaths in 2022.1 The WHO proposes to end this global epidemic by 2035, which would necessitate reducing TB deaths by 95%, TB incidence by 90%, and eliminating catastrophic costs for TB-affected households compared with the 2015 levels. There is doubt this can be achieved. An established
-
Air pollution and respiratory health in patients with COPD: should we focus on indoor or outdoor sources? Thorax (IF 9.0) Pub Date : 2024-12-01 Dimitris Evangelopoulos, Hanbin Zhang, Lia Chatzidiakou, Heather Walton, Klea Katsouyanni, Roderic L Jones, Jennifer K Quint, Benjamin Barratt
Introduction While associations between ambient air pollution and respiratory health in chronic obstructive pulmonary disease (COPD) patients are well studied, little is known about individuals’ personal exposure to pollution and associated health effects by source. Aim To separate measured total personal exposure into indoor-generated and outdoor-generated pollution and use these improved metrics
-
CD206+ macrophages are relevant non-invasive imaging biomarkers and therapeutic targets in experimental lung fibrosis Thorax (IF 9.0) Pub Date : 2024-12-01 Lenny Pommerolle, Guillaume Beltramo, Leo Biziorek, Marin Truchi, Alexandre Magno Maneschy Dias, Lucile Dondaine, Julie Tanguy, Nicolas Pernet, Victor Goncalves, Alexanne Bouchard, Marie Monterrat, Grégoire Savary, Nicolas Pottier, Kjetil Ask, Martin R J Kolb, Bernard Mari, Carmen Garrido, Bertrand Collin, Philippe Bonniaud, Olivier Burgy, Françoise Goirand, Pierre-Simon Bellaye
Background Interstitial lung diseases (ILDs) include a large number of diseases associated with progressive pulmonary fibrosis (PPF), including idiopathic pulmonary fibrosis (IPF). Despite the rarity of each of the fibrotic ILDs individually, they cumulatively affect a considerable number of patients. PPF is characterised by an excessive collagen deposition leading to functional decline. Objectives
-
Plasma collagen neoepitopes are associated with multiorgan disease in the ACCESS and GRADS sarcoidosis cohorts Thorax (IF 9.0) Pub Date : 2024-12-01 Jannie Marie Bülow Sand, Henrik Jessen, Diana Julie Leeming, Sheeline Yu, Chris J Lee, Buqu Hu, Ying Sun, Taylor Adams, Taylor Pivarnik, Angela Liu, Samuel Woo, John R McGovern, Vitória Fiorini, Tina Saber, Jean Paul Higuero-Sevilla, Mridu Gulati, Naftali Kaminski, William Damsky, Albert C Shaw, Subhasis Mohanty, Gillian Goobie, Yingze Zhang, Erica Lyndrup Herzog, Changwan Ryu
Introduction The pathogenesis of sarcoidosis involves tissue remodelling mediated by the accumulation of abnormal extracellular matrix, which is partly the result of an imbalance in collagen synthesis, cross-linking and degradation. During this process, collagen fragments or neoepitopes, are released into the circulation. The significance of these circulating collagen neoepitopes in sarcoidosis remains
-
Variability in forced expiratory volume in 1 s in children with symptomatically well-controlled asthma Thorax (IF 9.0) Pub Date : 2024-12-01 Nicole Filipow, Stephen Turner, Helen L Petsky, Anne B Chang, Thomas Frischer, Stanley Szefler, Francoise Vermeulen, Sanja Stanojevic
Aims Spirometry is used by many clinicians to monitor asthma in children but relatively little is understood about its variability over time. The aim of this study was to determine the variability of forced expiratory volume in 1 s (FEV1) in children with symptomatically well-controlled asthma by applying three different methods of expressing change in FEV1 over 3-month intervals. Methods Data from
-
Platelet aggregates in lung capillaries in severely decompensated pulmonary hypertension Thorax (IF 9.0) Pub Date : 2024-12-01 Camille Miard, Vincent Thomas de Montpreville, Jean-François Bernaudin, Julien Adam, Chakib Djediat, Francois Stephan
The mechanism of thrombocytopenia during acute pulmonary hypertension (PH) decompensation may be partly due to platelet aggregation in the lung. Platelet aggregates in explanted lung from 16 lung transplant patients during acute PH decompensation with and without thrombocytopenia were identified by immunohistochemistry. Scanning electron microscopy (SEM) was performed. 7 explant lung controls without
-
A structural and metabolic framework for classifying pre-clinical tuberculosis infection phenotypes using 18F-FDG PET-CT: a prospective cohort analysis following M. tuberculosis exposure Thorax (IF 9.0) Pub Date : 2024-12-01 Jee Whang Kim, Sonam Vadera, Meedya Sharifpour, Amrita Bajaj, Anver Kamil, Pranabashis Haldar
Tuberculosis (TB) control efforts are limited by ineffective characterisation of tuberculosis infection (TBI) —a heterogeneous spectrum of pre-clinical infection states, invisible to tools of routine clinical screening, that are associated with variable risk of progression to TB disease. In this prospective study, we use positron emission tomography-CT (PET-CT) as a high-resolution imaging modality
-
Multiple lung cyst formation caused by metastatic bladder cancer Thorax (IF 9.0) Pub Date : 2024-12-01 Noriaki Nakagaki, Masashi Komori, Tatsuro Shimokama, Eiji Iwama
A 90-year-old man visited our hospital with a chief problem of haemoptysis lasting for a month. He had a medical history of bladder cancer, including transurethral resection, 10 years previously. Chest and abdominal CT demonstrated a large cystic lesion with thin walls surrounded by infiltration and ground-glass opacities in the left lower lobe of the lung (figure 1A), with no findings of bladder cancer
-
Pulmonary fibrosis may begin in infancy: from childhood to adult interstitial lung disease Thorax (IF 9.0) Pub Date : 2024-12-01 Matthias Griese, Geoffrey Kurland, Michal Cidon, Robin R Deterding, Ralph Epaud, Nadia Nathan, Nicolaus Schwerk, David Warburton, Jason P Weinman, Lisa R Young, Gail H Deutsch
Background Childhood interstitial lung disease (chILD) encompasses a group of rare heterogeneous respiratory conditions associated with significant morbidity and mortality. Reports suggest that many patients diagnosed with chILD continue to have potentially progressive or fibrosing disease into adulthood. Over the last decade, the spectrum of conditions within chILD has widened substantially, with
-
Associations of pulmonary microvascular blood volume with per cent emphysema and CT emphysema subtypes in the community: the MESA Lung study Thorax (IF 9.0) Pub Date : 2024-11-04 Emilia A Hermann, Amin Motahari, Eric A Hoffman, Yifei Sun, Norrina Allen, Elsa D Angelini, Alain G Bertoni, David A Bluemke, Sarah E Gerard, Junfeng Guo, David W Kaczka, Andrew Laine, Erin Michos, Prashant Nagpal, James S Pankow, Coralynn S Sack, Benjamin Smith, Karen Hinckley Stukovsky, Karol E Watson, Artur Wysoczanski, R Graham Barr
Background Pulmonary microvasculature alterations are implicated in emphysema pathogenesis, but the association between pulmonary microvascular blood volume (PMBV) and emphysema has not been directly assessed at scale, and prior studies have used non-specific measures of emphysema. Methods The Multi-Ethnic Study of Atherosclerosis Lung Study invited participants recruited from the community without
-
Community-based approaches to improve tuberculosis services: observations from preintervention and postintervention surveys in a high TB burden disadvantaged community in India Thorax (IF 9.0) Pub Date : 2024-10-26 Jyothi Bhat, Ravendra Kumar Sharma, Rajiv Yadav, M Muniyandi, Prashant Mishra, Samridhi Nigam, Mercy Aparna Latha Lingala, Vikas Gangadhar Rao
An alarmingly high prevalence of tuberculosis (TB) was reported among the Saharia tribe in Madhya Pradesh, India. A community-based intervention study was undertaken to improve TB case finding during 2018–2021. The interventions mainly comprised active case detection through village TB volunteers using advocacy, communication and social mobilisation activities. A preintervention and postintervention
-
Pulmonary infection caused by Talaromyces amestolkiae Thorax (IF 9.0) Pub Date : 2024-10-16 Chiqing Ying, Lvjun Zhang, Xuehang Jin, Hui Chen, Dan Zhu
A 38-year-old woman was admitted for uterine fibroid surgery. A routine preoperative CT chest scan identified bilateral patchy, high-density shadows, with unclear boundaries, more evident in the upper lobes (figure 1A). She had no respiratory symptoms, such as coughing or expectoration, and was an office worker with allergies to seafood and mango. She denied having comorbidities including diabetes
-
Inequalities in care and the burden of wheeze and asthma in young children from diverse socioeconomic and ethnic backgrounds Thorax (IF 9.0) Pub Date : 2024-11-01 Björn Nordlund
Worldwide inequalities in care significantly impact respiratory health outcomes.1 2 Despite this, there are few studies examining how wheeze and asthma outcomes, including healthcare use and treatment decisions, vary with socioeconomic status and ethnicity in young children. Therefore, it is highly relevant to acknowledge the paper by D Lo et al , ‘Association between socioeconomic deprivation, ethnicity
-
Harm from tobacco: a common thread Thorax (IF 9.0) Pub Date : 2024-11-01 Sanjay Agrawal
Industry uses market segmentation of products to attract and retain consumers from a variety of groups based on demographics, interests, behavioural factors and common needs. This approach is used across many commercial sectors selling a diverse range of commodities including cleaning, beauty, food, automobile and electronic products. Consumers may be attracted to goods based on a number of characteristics
-
Editorial of utility of the Global Lung Function Initiative (GLI) for ILD Thorax (IF 9.0) Pub Date : 2024-11-01 Tomoo Kishaba
Interstitial lung disease (ILD) is a heterogeneous parenchymal disorder.1 2 Patients with ILD often present with non-specific symptoms such as a non-productive cough and exertional dyspnoea. The differential diagnosis for ILD is broad and includes conditions such as connective tissue disease (CTD), hypersensitivity pneumonitis, drug-associated ILD and granulomatous diseases. Furthermore, the initial
-
Predicting the risk of pulmonary deterioration in sarcoidosis Thorax (IF 9.0) Pub Date : 2024-11-01 Elizabeth V Arkema, Pernilla Lindin Darlington, Yvette C Cozier
In sarcoidosis, any organ may be affected, and the majority of cases have pulmonary involvement. The disease course in pulmonary sarcoidosis varies considerably, from complete resolution to chronic disease and/or pulmonary fibrosis. The heterogeneity of sarcoidosis is a major challenge in treatment decision-making, and the hope is that subgrouping patients into phenotypes may help to provide the right
-
Consensus palliative care referral criteria for people with chronic obstructive pulmonary disease Thorax (IF 9.0) Pub Date : 2024-11-01 Jennifer Philip, Yuchieh Kathryn Chang, Anna Collins, Natasha Smallwood, Donald Richard Sullivan, Barbara P Yawn, Richard Mularski, Magnus Ekström, Ian A Yang, Christine F McDonald, Masanori Mori, Pedro Perez-Cruz, David M G Halpin, Shao-Yi Cheng, David Hui
Objective People with advanced chronic obstructive pulmonary disease (COPD) have substantial palliative care needs, but uncertainty exists around appropriate identification of patients for palliative care referral. We conducted a Delphi study of international experts to identify consensus referral criteria for specialist outpatient palliative care for people with COPD. Methods Clinicians in the fields
-
Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD Thorax (IF 9.0) Pub Date : 2024-11-01 Fu-Shun Yen, Chih-Cheng Hsu, James Cheng-Chung Wei, Fuu-Jen Tsai, Yuhan Huang, Teng-Shun Yu, Chii-Min Hwu
Background Clinical studies have shown that glucagon-like peptide-1 receptor agonists (GLP-1 RA) can have beneficial effects on cardiopulmonary function. We conducted this longitudinal cohort study to compare the risk of cardiopulmonary outcomes and mortality between GLP-1 RA use and no use in patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disease (COPD). Methods The study identified
-
Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease Thorax (IF 9.0) Pub Date : 2024-11-01 Andrew Li, Alan Teoh, Lauren Troy, Ian Glaspole, Margaret L Wilsher, Sally de Boer, Jeremy Wrobel, Yuben P Moodley, Francis Thien, Henry Gallagher, Michelle Galbraith, Daniel C Chambers, John Mackintosh, Nicole Goh, Yet Hong Khor, Adrienne Edwards, Karen Royals, Christopher Grainge, Benjamin Kwan, Gregory J Keir, Chong Ong, Paul N Reynolds, Elizabeth Veitch, Gin Tsen Chai, Ziqin Ng, Geak Poh Tan, Dan
Background Lung function testing remains a cornerstone in the assessment and management of interstitial lung disease (ILD) patients. The clinical implications of the Global Lung function Initiative (GLI) reference equations and the updated interpretation strategies remain uncertain. Methods Adult patients with ILD with baseline forced vital capacity (FVC) were included from the Australasian ILD registry
-
Pulmonary sarcoidosis: differences in lung function change over time Thorax (IF 9.0) Pub Date : 2024-11-01 Michelle Sharp, Kevin J Psoter, Ali M Mustafa, Edward S Chen, Nancy W Lin, Stephen C Mathai, Nisha A Gilotra, Michelle N Eakin, Robert A Wise, David R Moller, Meredith C McCormack
Introduction Given the heterogeneity of sarcoidosis, predicting disease course of patients remains a challenge. Our aim was to determine whether the 3-year change in pulmonary function differed between pulmonary function phenotypes and whether there were differential longitudinal changes by race and sex. Methods We identified individuals seen between 2005 and 2015 with a confirmed diagnosis of sarcoidosis
-
Software using artificial intelligence for nodule and cancer detection in CT lung cancer screening: systematic review of test accuracy studies Thorax (IF 9.0) Pub Date : 2024-11-01 Julia Geppert, Asra Asgharzadeh, Anna Brown, Chris Stinton, Emma J Helm, Surangi Jayakody, Daniel Todkill, Daniel Gallacher, Hesam Ghiasvand, Mubarak Patel, Peter Auguste, Alexander Tsertsvadze, Yen-Fu Chen, Amy Grove, Bethany Shinkins, Aileen Clarke, Sian Taylor-Phillips
Objectives To examine the accuracy and impact of artificial intelligence (AI) software assistance in lung cancer screening using CT. Methods A systematic review of CE-marked, AI-based software for automated detection and analysis of nodules in CT lung cancer screening was conducted. Multiple databases including Medline, Embase and Cochrane CENTRAL were searched from 2012 to March 2023. Primary research
-
Association between socioeconomic deprivation, ethnicity and health outcomes in preschool children with recurrent wheeze in England: a retrospective cohort study Thorax (IF 9.0) Pub Date : 2024-11-01 David Lo, Claire Lawson, Clare Gillies, Sharmin Shabnam, Erol A Gaillard, Hilary Pinnock, Jennifer K Quint
Background Preschool-aged children have among the highest burden of acute wheeze. We investigated differences in healthcare use, treatment and outcomes for recurrent wheeze/asthma in preschoolers from different ethno-socioeconomic backgrounds. Methods Retrospective cohort study using data from the Clinical Practice Research Datalink linked to Hospital Episode Statistics in England. We reported number
-
Non-cigarette tobacco products, aryl-hydrocarbon receptor repressor gene methylation and smoking-related health outcomes Thorax (IF 9.0) Pub Date : 2024-11-01 Christina M Eckhardt, Pallavi Balte, Jack E Morris, Surya P Bhatt, David Couper, Jessica Fetterman, Neal Freedman, David R Jacobs, Lifang Hou, Ravi Kalhan, Yongmei Liu, Laura Loehr, Pamela L Lutsey, Joseph E Schwartz, Wendy White, Sachin Yende, Stephanie J London, Tiffany R Sanchez, Elizabeth C Oelsner
Introduction Cigarette smoking leads to altered DNA methylation at the aryl-hydrocarbon receptor repressor (AHRR) gene. However, it remains unknown whether pipe or cigar smoking is associated with AHRR methylation. We evaluated associations of non-cigarette tobacco use with AHRR methylation and determined if AHRR methylation was associated with smoking-related health outcomes. Methods Data were pooled
-
Impact of TAS2R38 polymorphisms on nasal nitric oxide and Pseudomonas infections in primary ciliary dyskinesia: relation to genotype Thorax (IF 9.0) Pub Date : 2024-11-01 Massimo Pifferi, Attilio Boner, Debora Maj, Angela Michelucci, Gabriele Donzelli, Angela M Cangiotti, Raffaella Guazzo, Giulia Bertolucci, Veronica Bertini, Chiara Doccioli, Michele Piazza, Angelo Valetto, Maria Adelaide Caligo, Diego Peroni, Andrew Bush
Objective Primary ciliary dyskinesia (PCD) severity has been related to genotype and levels of nasal nitric oxide (nNO). The most common TAS2R38 haplotypes (PAV/PAV, PAV/AVI, AVI/AVI) encoding the bitter taste receptor can affect nNO levels and thus could play a role in the susceptibility to respiratory infections. We assessed the impact of these polymorphisms on nNO production and Pseudomonas aeruginosa
-
Association of positive airway pressure termination with mortality and non-fatal cardiovascular events in patients with obstructive sleep apnoea Thorax (IF 9.0) Pub Date : 2024-11-01 AbdelKebir Sabil, Claire Launois, Wojchiech Trzepizur, François Goupil, Thierry Pigeanne, Sandrine Launois, Laurène Leclair-Visonneau, Philippe Masson, Acya Bizieux-Thaminy, Sandrine Kerbat, Sebastien Bailly, Frédéric Gagnadoux
Background and aims The recurrence of obstructive sleep apnoea (OSA) after positive airway pressure (PAP) therapy termination has physiological consequences that may increase cardiovascular (CV) risk. We aimed to determine whether PAP termination is associated with an increased incidence of major adverse CV events (MACE) compared with adherent PAP continuation. Methods Data from the Pays de la Loire
-
Effect of mesenchymal stem cells on the host response in severe community-acquired pneumonia Thorax (IF 9.0) Pub Date : 2024-11-01 Tom D Y Reijnders, Pierre-François Laterre, Bruno François, Miguel Sánchez García, Tjitske S R van Engelen, Daoud Sie, Brendon P Scicluna, Dmitry V Ostanin, Kevin J Galinsky, Joe M Butler, Eleuterio Lombardo, Tom van der Poll
Mesenchymal stem cells (MSC) have immune regulatory properties that may ameliorate pathophysiological processes in sepsis. We determined the effect of allogeneic adipose-derived MSCs (Cx611) on the host response during sepsis due to community-acquired bacterial pneumonia (CABP) by measuring 29 plasma biomarkers and blood transcriptomes at six time points in 82 patients randomised to two intravenous
-
Unusual cause of trepopnea Thorax (IF 9.0) Pub Date : 2024-11-01 Suat Yee Lee, Juo-Hau Su, Chia-Chen Chang, Fatt Yang Chew
A 19-year-old female presented with a 6-month history of progressive shortness of breath. She reported a new onset of palpitations preceding her shortness of breath, which progressed progressively into dull chest pain and trepopnea, and she experienced dyspnoea while lying on her right side. With wheezing and rhinorrhoea, the symptoms became more prominent. She had no previous history of haemoptysis
-
Perivascular epithelioid cell neoplasm of lung Thorax (IF 9.0) Pub Date : 2024-11-01 Hong Yang, Binglin Lai
A 73-year-old woman was found to have a pulmonary mass on a CT scan of the chest 10 years ago, but did not receive any treatment. Approximately 2 years ago, she started experiencing chest tightness and bloating, without other discomfort. These symptoms worsened half a month ago and were accompanied by dyspnoea. A CT scan (figure 1A,D) revealed a spherical mass in the left upper lobe lingular segment
-
Chronic berylliosis disease: uncommon pulmonary granulomas beyond sarcoidosis Thorax (IF 9.0) Pub Date : 2024-11-01 Ahmed Ehab, Axel T Kempa, Liubov Yurkul, Ahmad Shalabi
A 47-year-old male presented with chronic cough, which has worsened over the last 5–6 months. Dyspnoea, fever and significant weight loss were denied. The patient had no history of smoking or vaping. The patient worked as an automotive technician in a car manufacturing plant specialised in aluminium-based vehicle bodies with frequent exposure to metallic fumes during polishing and welding of aluminium/beryllium
-
Refractory granulomatous Pneumocystis jirovecii pneumonia masquerading as malignancy Thorax (IF 9.0) Pub Date : 2024-11-01 Chi Wan Koo, Ananya Panda, Jennifer Boland Froemming
An elderly female, lifelong non-smoker, with rheumatoid arthritis treated with methotrexate and prednisone for 10 years was referred for evaluation of incidentally detected, randomly distributed pulmonary nodules on a CT performed for pleuritic chest pain and dyspnoea (figure 1A). Subsequent [18F]fluoro-d-glucose (FDG)-positron emission tomography (PET) showed the nodules had increased in size and
-
Sleep-disordered breathing in children and adults with intellectual disability: mind the gap! Thorax (IF 9.0) Pub Date : 2024-11-01 Renata L Riha, Ankur Singh, Elizabeth A Hill, Hazel Evans, David O'Regan
Background In adults and children with intellectual disability (ID), sleep -disordered breathing (SDB) is thought to be common. However, large epidemiological studies are lacking, and there are few studies on optimal methods of investigation and even fewer randomised, controlled intervention trials of treatment. Method Peer-reviewed publications from various databases were examined in line with search
-
Journal club Thorax (IF 9.0) Pub Date : 2024-11-01 Anthony W Martinelli
The ACCESS trial ( Lancet Respir Med 2024;12(4):294–304) provides new evidence supporting the use of macrolides in community-acquired pneumonia (CAP). In this prospective, double-blind study, Giamarellos-Bourboulis and colleagues randomised patients admitted with CAP and receiving intravenous antibiotics to addition of either oral clarithromycin or placebo for 7 days. Participants from 18 Greek hospitals
-
Association of fluoroquinolones with the risk of spontaneous pneumothorax: nationwide case–time–control study Thorax (IF 9.0) Pub Date : 2024-10-11 Anne Bénard-Laribière, Elodie Pambrun, Serge Kouzan, Jean-Luc Faillie, Julien Bezin, Antoine Pariente
Introduction Fluoroquinolones can cause severe collagen-associated adverse effects, potentially impacting the pulmonary connective tissue. We investigated the association between fluoroquinolones and spontaneous pneumothorax. Methods A case–time–control study was performed using the nationwide French reimbursement healthcare system database (SNDS). Cases were adults ≥18 years admitted for spontaneous
-
Effect of nostril occlusion and mouth sealing in the measurement of sniff nasal inspiratory pressure Thorax (IF 9.0) Pub Date : 2024-10-07 Neeraj M Shah, Anne Rossel, Bawan Abdulaziz, Shauna Sheridan, Sophie Madden-Scott, Gillian Radcliffe, Rebecca D’Cruz, Eui-Sik Suh, Joerg Steier, Nicholas Hart, Patrick Brian Murphy, Michelle Ramsay, Georgios Kaltsakas
Sniff nasal inspiratory pressure (SNIP) is used to assess respiratory muscle strength in neuromuscular diseases like amyotrophic lateral sclerosis (ALS). The effect of contralateral nostril occlusion and mouth sealing on SNIP measurement are unclear. 81 participants were included (16 healthy, 39 patients with limb-onset ALS and 26 patients with bulbar-onset ALS). SNIP was obtained with combinations
-
Artificial stone silicosis arrives in the UK: a tragic case of history repeating Thorax (IF 9.0) Pub Date : 2024-10-01 Christopher Barber
Silicosis is the most ancient form of occupational lung disease, being known to have caused disability and the premature death of workers for many millennia.1 Despite this, silicosis continues to be a global health problem,2 accounting for almost 13 000 deaths worldwide in 2019.3 Those at risk of this disease commonly work in industries that involve either cutting through silica-containing material
-
Implications of the hypobaric cabin environment during commercial air travel for passenger fitness to fly Thorax (IF 9.0) Pub Date : 2024-10-01 Peter D Hodkinson, Thomas G Smith
In 2019, a record 4.5 billion passengers travelled by air.1 This fell markedly during the COVID-19 pandemic, but in 2023, the industry’s measure of overall airline ‘traffic’, revenue passenger kilometres, was back to 94% of the 2019 figures, with predictions that 2024 will see new record passenger numbers (see figure 1).2 This highlights how common air travel is and reinforces the idea that it is highly
-
Untangling the web between menopause and respiratory disease Thorax (IF 9.0) Pub Date : 2024-10-01 Hannah Whittaker
Over the last few decades, women’s health has slowly shifted closer to the forefront of research.1 There have been multiple major campaigns at academic, charity and government level, for the improvement of women’s health globally. In 2021, the UK government implemented the Women’s Health Strategy to improve the health of women in the UK over 10 years and Asthma and Lung UK published their report on
-
Ageing and ivacaftor: unravelling the long-term effects Thorax (IF 9.0) Pub Date : 2024-10-01 Paul D Robinson
The cystic fibrosis transmembrane conductance regulator (CFTR) modulator compound, ivacaftor, reached its 10-year anniversary of US Food and Drug Administration (FDA) approval in 2022. This long-standing experience captured within US CF foundation patient registry (US CFFPR) data up to December 2019 was harnessed by Merlo and colleagues in this edition of the journal to provide further insight into
-
Antenatal exposures to tobacco and biomass or fossil fuels and wheezing in early childhood in South Africa Thorax (IF 9.0) Pub Date : 2024-10-01 Rachel Nadif
Asthma is the most prevalent chronic disease of childhood. Based on the Global Burden of Diseases, Injuries and Risk Factors Study, the global incident cases of asthma in children increased by 7.07% from 1990 to 2019, the highest incidence being observed in children under 5 years old.1 Among these youngest children, asthma is difficult to diagnose, and is often defined by wheezing episodes characterised
-
Nasal epithelial gene expression identifies relevant asthma endotypes in the ATLANTIS study Thorax (IF 9.0) Pub Date : 2024-10-01 Tatiana Karp, Alen Faiz, Jos van Nijnatten, Huib A M Kerstjens, Ilse Boudewijn, Monica Kraft, Judith M Vonk, Martijn C Nawijn, Irene H Heijink, Bianca Beghé, Klaus F Rabe, Alberto Papi, Chris Brightling, Dave Singh, Thys van der Molen, Salman Siddiqui, Stephanie Christenson, Victor Guryev, Maarten van den Berge
Introduction Asthma is an inflammatory airways disease encompassing multiple phenotypes and endotypes. Several studies suggested gene expression in nasal epithelium to serve as a proxy for bronchial epithelium, being a non-invasive approach to investigate lung diseases. We hypothesised that molecular differences in upper airway epithelium reflect asthma-associated differences in the lower airways and
-
Impact of age at ivacaftor initiation on pulmonary outcomes among people with cystic fibrosis Thorax (IF 9.0) Pub Date : 2024-10-01 Christian A Merlo, Lisa J McGarry, Teja Thorat, Catherine Nguyen, Maral DerSarkissian, Aruna Muthukumar, Joe Healy, M Alan Brookhart, Jaime L Rubin
Background Ivacaftor (IVA) improves lung function and other extrapulmonary outcomes in people with cystic fibrosis (CF). However, the effect of initiating IVA at earlier versus later ages has not been studied. Methods We conducted an observational cohort study of people in the US CF Foundation Patient Registry aged ≥6 years with ≥1 CF transmembrane conductance regulator–gating mutation to compare the
-
Long-term impact of ivacaftor on mortality rate and health outcomes in people with cystic fibrosis Thorax (IF 9.0) Pub Date : 2024-10-01 Christian A Merlo, Teja Thorat, Maral DerSarkissian, Lisa J McGarry, Catherine Nguyen, Yuqian M Gu, Joe Healy, Jaime L Rubin, M Alan Brookhart
Background Ivacaftor (IVA) has been shown to improve lung function and other clinical outcomes in people with cystic fibrosis (CF). A decade of real-world IVA availability has enabled the examination of long-term outcomes with this treatment. This retrospective, longitudinal cohort study investigated the impact of IVA on mortality rate and health outcomes among people with CF in the US. Methods Data
-
Relationship between cumulative silica exposure and silicosis: a systematic review and dose-response meta-analysis Thorax (IF 9.0) Pub Date : 2024-10-01 Patrick Howlett, Jeffrey Gan, Maia Lesosky, Johanna Feary
Background Silicosis, a chronic respiratory disease caused by crystalline silica exposure, is a persistent global lung health issue. No systematic review of the relationship between cumulative respirable crystalline silica (RCS) exposure and silicosis exists. UK exposure limits are currently under review. We therefore performed a systematic review and dose-response meta-analysis of this relationship
-
Urban metabolic and airway immune profiles increase the risk of infections in early childhood Thorax (IF 9.0) Pub Date : 2024-10-01 Nicklas Brustad, Jonathan Thorsen, Casper Emil Tingskov Pedersen, Mina Ali, Julie Kyvsgaard, Sarah Brandt, Jenni Lehtimäki, Nicole Prince, Nilofar V Følsgaard, Jessica Lasky-Su, Jakob Stokholm, Klaus Bønnelykke, Bo Chawes
Background Infections in childhood remain a leading global cause of child mortality and environmental exposures seem crucial. We investigated whether urbanicity at birth was associated with the risk of infections and explored underlying mechanisms. Methods Children (n=633) from the COPSAC2010 mother–child cohort were monitored daily with symptom diaries of infection episodes during the first 3 years
-
Environmental exposures associated with early childhood recurrent wheezing in the mother and child in the environment birth cohort: a time-to-event study Thorax (IF 9.0) Pub Date : 2024-10-01 Kareshma Asharam, Aweke A Abebaw Mitku, Lisa Ramsay, Prakash Mohan Jeena, Rajen N Naidoo
Background Antenatal factors and environmental exposures contribute to recurrent wheezing in early childhood. Aim To identify antenatal and environmental factors associated with recurrent wheezing in children from birth to 48 months in the mother and child in the environment cohort, using time-to-event analysis. Method Maternal interviews were administered during pregnancy and postnatally and children
-
Early menopause and hormone therapy as determinants for lung health outcomes: a secondary analysis using the PLCO trial Thorax (IF 9.0) Pub Date : 2024-10-01 Xiaochun Gai, Yue Feng, Tessa M Flores, Huining Kang, Hui Yu, Kimberly K Leslie, Yiliang Zhu, Jennifer A Doherty, Yan Guo, Steven A Belinsky, Linda S Cook, Shuguang Leng
Rationale Early natural menopause (early-M; <45 years of age) increases the risk of lung morbidities and mortalities in smokers. However, it is largely unknown whether early-M due to surgery demonstrates similar effects and whether menopausal hormone therapy (MHT) is protective against lung diseases. Objectives To assess the associations of early-M and MHT with lung morbidities and mortalities using
-
Effects of moderate alcohol consumption and hypobaric hypoxia: implications for passengers’ sleep, oxygen saturation and heart rate on long-haul flights Thorax (IF 9.0) Pub Date : 2024-10-01 Rabea Antonia Trammer, Daniel Rooney, Sibylle Benderoth, Martin Wittkowski, Juergen Wenzel, Eva-Maria Elmenhorst
Background Passengers on long-haul flights frequently consume alcohol. Inflight sleep exacerbates the fall in blood oxygen saturation (SpO2) caused by the decreased oxygen partial pressure in the cabin. We investigated the combined influence of alcohol and hypobaric hypoxia on sleep, SpO2 and heart rate. Methods Two groups of healthy individuals spent either two nights with a 4-hour sleep opportunity
-
Artificial stone silicosis: a UK case series Thorax (IF 9.0) Pub Date : 2024-10-01 Johanna Feary, Anand Devaraj, Matthew Burton, Felix Chua, Robina K Coker, Arnab Datta, Richard J Hewitt, Maria Kokosi, Vaslis Kouranos, Carl Jonathan Reynolds, Clare L Ross, Veronica Smith, Katie Ward, Melissa Wickremasinghe, Joanna Szram
Silicosis due to artificial stone (AS) has emerged over the last decade as an increasing global issue. We report the first eight UK cases. All were men; median age was 34 years (range 27–56) and median stone dust exposure was 12.5 years (range 4–40) but in 4 cases was 4–8 years. One is deceased; two were referred for lung transplant assessment. All cases were dry cutting and polishing AS worktops with
-
Pulmonary fibrosis and lung cancer: an analysis of the Clinical Practice Research Datalink linked to the National Cancer Registration Dataset Thorax (IF 9.0) Pub Date : 2024-10-01 Francesca Gonnelli, Jaspreet Kaur, Martina Bonifazi, David Baldwin, Emma O’Dowd, Richard Hubbard
We quantified the proportion of diagnoses of pulmonary fibrosis (PF) among 25 136 people with lung cancer and 250 583 matched controls and compared the natural history of lung cancer in people with and without PF. Diagnoses of PF were more common in people with lung cancer than those without (1.5% vs 0.8%, OR 1.97; 95% CI 1.77 to 2.21). Within people with PF, squamous cell carcinoma was more (22.9% vs
-
Multiple intrathoracic extramedullary haematopoiesis as visualised on medical thoracoscopy Thorax (IF 9.0) Pub Date : 2024-10-01 Jiun Hang Lee, Larry Ellee Nyanti, Nai-Chien Huan, Hema Yamini Ramarmuty, Kunji Kannan Sivaraman Kannan
A 38-year-old man with underlying transfusion-dependent beta-thalassemia and a history of splenectomy in August 2023 presented in December of the same year, complaining of one month of dyspnoea and orthopnoea. The chest radiograph revealed bilateral pleural effusion, with a left-sided predominance. Diagnostic and therapeutic thoracentesis demonstrated straw-coloured serous pleural fluid (pf) with an
-
Intensive care unit interventions to promote sleep and circadian biology in reducing incident delirium: a scoping review Thorax (IF 9.0) Pub Date : 2024-10-01 M Elizabeth Wilcox, Lisa Burry, Marina Englesakis, Briar Coman, Marietou Daou, Frank MP van Haren, E Wes Ely, Karen J Bosma, Melissa P Knauert
Rationale/Objectives Despite plausible pathophysiological mechanisms, research is needed to confirm the relationship between sleep, circadian rhythm and delirium in patients admitted to the intensive care unit (ICU). The objective of this review is to summarise existing studies promoting, in whole or in part, the normalisation of sleep and circadian biology and their impact on the incidence, prevalence
-
Journal club Thorax (IF 9.0) Pub Date : 2024-10-01 Ewan Christopher Mackay
Household air pollution has been estimated to be responsible for 3.2 million preventable deaths every year globally. With biomass exposure and environmental pollution linked to exacerbations of airways disease, this health impact disproportionately affects low and middle income countries. Puzzolo et al ( Lancet Resp Med 2024;12(4):281–293) undertook a systematic review and included 116 studies in the
-
Consolidation with pseudocavitation Thorax (IF 9.0) Pub Date : 2024-08-30 Tanzil Rahaman, Kavitha Venkatnarayan, Chitra Veluthat, Priya Ramachandran
A 48-year-old man, non-smoker, with no known comorbidities, presented with shortness of breath, cough with mucoid expectoration, loss of appetite and loss of weight for 6 weeks. There was no history of fever, hemoptysis or wheezing. He had received multiple courses of antibiotics from elsewhere before presenting to our centre with no relief of symptoms. On examination, crepitations were audible in
-
Atypical radiological manifestation of sarcoidosis presenting with an anterior mediastinal mass Thorax (IF 9.0) Pub Date : 2024-08-22 Wan-Ting Tao, Hao-Yu Huang, Wen-Chiuan Tsai, Kai-Hsiung Ko
A 44-year-old woman presented with a persistent diffuse skin rash for 3 months, along with progressively worsening dyspnoea, cough and fatigue over the past 2 weeks. Laboratory results and physical examination were unremarkable, except for decreased breath sounds over the right lung and multiple palpable nodular skin lesions over the chest, abdomen and limbs (figure 1). Chest radiograph revealed a
-
Xpert Ultra for diagnosing tuberculosis at bronchoscopy: thoughts on practical applications Thorax (IF 9.0) Pub Date : 2024-09-01 Graham Bothamley
Tests based on polymerase chain reactions are increasingly important in the microbiological diagnosis of tuberculosis (TB). Park et al1 have extended the use of Xpert Ultra to include material obtained at bronchoscopy, and particularly its use for samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). In addition, immediate cytology with rapid onsite evaluation
-
Rectal organoid morphometric analysis (ROMA)—re: optimising measurements automatically Thorax (IF 9.0) Pub Date : 2024-09-01 Shafagh Waters, Peter G Middleton
Quantification of the physiological changes in people with cystic fibrosis (pwCF) has long been important for clinical diagnosis. Since the original discovery of abnormal sweat electrolytes in pwCF, the standardised pilocarpine iontophoresis sweat test was developed1 to clearly distinguish those with CF. While the sweat chloride test remains an important early step in the diagnostic algorithm, complementary
-
Cause or consequence in idiopathic pulmonary fibrosis: using genetic data to back the right horse Thorax (IF 9.0) Pub Date : 2024-09-01 Louise V Wain
The task is clear: we need better treatments for pulmonary fibrosis (PF). The two antifibrotic therapies licensed for idiopathic pulmonary fibrosis (IPF) have shown efficacy in other forms of PF but do not meet the needs of people living with PF; drugs that can halt or even reverse progression and, importantly, improve quality of life. Although a number of new potential therapies are now reaching late-stage
-
Unveiling the occupational hazards: exploring the association between organic dust exposure and hypersensitivity pneumonitis and other interstitial lung diseases Thorax (IF 9.0) Pub Date : 2024-09-01 Sheikh M Alif, Geza Benke
Organic dusts are mixtures of particles originating from plants, animals and often endotoxins from gram-negative bacteria. Several occupations, including farming (where exposures can occur during grain, animal handling and feeding), woodworking (where exposures can occur from wood dust) and textile work (during cotton processing), are the primary sources of occupational exposure to organic dust.1 2